<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M800</article-id>
      <article-id pub-id-type="publisher-id">molbank-2013-M800</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>2-{[5-(Diphenylmethyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-<italic>N</italic>-(pyrazin-2-yl)acetamide</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Nayak</surname>
            <given-names>Prakash S.</given-names>
          </name>
          <xref rid="af1-molbank-2013-M800" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Narayana</surname>
            <given-names>Badiadka</given-names>
          </name>
          <xref rid="af1-molbank-2013-M800" ref-type="aff">1</xref>
          <xref rid="c1-molbank-2013-M800" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Samshuddin</surname>
            <given-names>Seranthimata</given-names>
          </name>
          <xref rid="af1-molbank-2013-M800" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sarojini</surname>
            <given-names>Balladka Kunhanna</given-names>
          </name>
          <xref rid="af2-molbank-2013-M800" ref-type="aff">2</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2013-M800"><label>1</label>Department of Studies in Chemistry, Mangalore University, Mangalagangotri-574 199, Karnataka, India</aff>
      <aff id="af2-molbank-2013-M800"><label>2</label>Research Department of Chemistry, P. A. College of Engineering, Nadupadavu, Mangalore 574153, Karnataka, India</aff>
      <author-notes>
        <corresp id="c1-molbank-2013-M800"><label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>nbadiadka@yahoo.co.uk</email>.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>03</day>
        <month>05</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>06</month>
        <year>2013</year>
      </pub-date>
      <volume>2013</volume>
      <issue>2</issue>
      <elocation-id>M800</elocation-id>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>03</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>04</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2013 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p><italic>S</italic>-Alkylation of 5-(diphenylmethyl)-1,3,4-oxadiazole-2(3<italic>H</italic>)-thione (<bold>3</bold>) by 2-chloro-<italic>N</italic>-(pyrazin-2-yl)acetamide (<bold>2</bold>) affords the title compound, 2-{[5-(diphenylmethyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-<italic>N</italic>-(pyrazin-2-yl)acetamide (<bold>4</bold>). The intermediate (<bold>2</bold>), in turn, was prepared by the acetylation of 2-aminopyrazine (<bold>1</bold>) with chloroacetyl chloride. The structure of the newly synthesized compound is characterized by IR, NMR and mass spectral data.</p>
      </abstract>
      <kwd-group>
        <kwd>1,3,4-oxadiazole</kwd>
        <kwd>pyrazine</kwd>
        <kwd><italic>S</italic>-alkylation</kwd>
        <kwd>thioether</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Thioethers have emerged as preeminent classes of organic compounds, which hold useful applications as key reagents in organic synthesis, bioorganic, medicinal, and heterocyclic chemistry [<xref ref-type="bibr" rid="B1-molbank-2013-M800">1</xref>,<xref ref-type="bibr" rid="B2-molbank-2013-M800">2</xref>,<xref ref-type="bibr" rid="B3-molbank-2013-M800">3</xref>,<xref ref-type="bibr" rid="B4-molbank-2013-M800">4</xref>]. Thioether derivatives have been the subject of investigation due to their different properties such as antibacterial [<xref ref-type="bibr" rid="B5-molbank-2013-M800">5</xref>] and antifungal [<xref ref-type="bibr" rid="B6-molbank-2013-M800">6</xref>] activities. Literature survey reveals that pyrazine derivatives showed pronounced antiauxin [<xref ref-type="bibr" rid="B7-molbank-2013-M800">7</xref>], antimycobacterial [<xref ref-type="bibr" rid="B8-molbank-2013-M800">8</xref>], antimicrobial, and anticancer [<xref ref-type="bibr" rid="B9-molbank-2013-M800">9</xref>] activities. On the other hand, a wide range of biological activities like, antiinflammatory [<xref ref-type="bibr" rid="B10-molbank-2013-M800">10</xref>], analgesic [<xref ref-type="bibr" rid="B11-molbank-2013-M800">11</xref>], antimicrobial [<xref ref-type="bibr" rid="B12-molbank-2013-M800">12</xref>,<xref ref-type="bibr" rid="B13-molbank-2013-M800">13</xref>] <italic>etc.</italic>, have been attributed to the compounds containing 1,3,4-oxadiazole ring system [<xref ref-type="bibr" rid="B14-molbank-2013-M800">14</xref>,<xref ref-type="bibr" rid="B15-molbank-2013-M800">15</xref>,<xref ref-type="bibr" rid="B16-molbank-2013-M800">16</xref>,<xref ref-type="bibr" rid="B17-molbank-2013-M800">17</xref>]. In view of the importance of thioethers, pyrazines and 1,3,4-oxadiazoles, it was aimed to synthesize the title compound, with the combination of three pharmacophore groups.</p>
    </sec>
    <sec sec-type="results">
      <title>Results and Discussion</title>
      <p>The title compound, 2-{[5-(diphenylmethyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-<italic>N</italic>-(pyrazin-2-yl)acetamide (<bold>4</bold>), was prepared by the regioselective <italic>S</italic>-alkylation of 5-(diphenylmethyl)-1,3,4-oxadiazole-2(3<italic>H</italic>)-thione (<bold>3</bold>) with 2-chloro-<italic>N</italic>-(pyrazin-2-yl)acetamide (<bold>2</bold>) (<xref ref-type="scheme" rid="molbank-2013-M800-sch001">Scheme <bold>1</bold></xref>). The intermediate <bold>2</bold>, in turn, was prepared by the reaction of 2-aminopyrazine (<bold>1</bold>) with 2-chloroacetylchloride in the presence potassium carbonate [<xref ref-type="bibr" rid="B16-molbank-2013-M800">16</xref>]. The other intermediate, 5-(diphenylmethyl)-1,3,4-oxadiazole-2(3<italic>H</italic>)-thione (<bold>3</bold>) was synthesized from diphenyl acetic acid according to the method described in our earlier work [<xref ref-type="bibr" rid="B17-molbank-2013-M800">17</xref>]. The title compound (<bold>4</bold>) was characterized by NMR, IR and mass spectral data. </p>
      <p>The formation of 2-{[5-(diphenylmethyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-<italic>N</italic>-(pyrazin-2-yl)acetamide (<bold>4</bold>) was confirmed by its NMR and mass spectral data. A singlet integrating for two protons at &#x3B4; 4.53 in the <sup>1</sup>H-NMR spectrum of compound (<bold>4</bold>) was due to -S-CH<sub>2</sub> linkage. Another singlet observed at &#x3B4; 5.93 ppm was due to the proton attached the carbon for which two phenyl groups were substituted. The signals of aromatic protons merged in the regions &#x3B4; 7.22&#x2013;7.36 ppm and 8.38&#x2013;8.41 ppm as multiplets. NH proton appeared as a singlet at &#x3B4; 11.15 ppm as a singlet. Mass spectrum showed a molecular ion peak at <italic>m/z</italic> 404.5 (M<sup>+</sup>+1) corresponding to the molecular formula of C<sub>21</sub>H<sub>17</sub>N<sub>5</sub>O<sub>2</sub>S. Elemental analysis and <sup>13</sup>C-NMR spectrum also gave satisfactory results for the title compound.</p>
    </sec>
    <sec sec-type="methods">
      <title>Experimental</title>
      <p>The melting point was taken in an open capillary tube and was uncorrected. The purity of the compound was confirmed by thin layer chromatography using Merck silica gel 60 F<sub>254</sub> coated aluminium plates. IR spectrum was recorded on Shimadzu-FTIR Infrared spectrometer in KBr (&#x3BD;<sub>max</sub> in cm<sup>&#x2212;1</sup>). <sup>1</sup>H-NMR (400 MHz) spectrum was recorded on a Varian 400 spectrometer, with 5 mm PABBO BB-1H TUBES and <sup>13</sup>C-NMR (100 MHz) spectrum was recorded for approximately 0.03 M solutions in DMSO at 100 MHz with TMS as internal standard. LCMS was obtained using an Agilent 1200 series LC and Micromass zQ spectrometer. Elemental analysis was carried out by using VARIO EL-III (Elementar Analysensysteme GmBH).</p>
      <p>The synthesis of 2-chloro-<italic>N</italic>-(pyrazin-2-yl)acetamide (<bold>2</bold>) was carried out by the reaction of 2-aminopyrazine (<bold>1</bold>) with 2-chloroacetyl chloride in the presence of K<sub>2</sub>CO<sub>3</sub> [<xref ref-type="bibr" rid="B18-molbank-2013-M800">18</xref>]. The other intermediate, 5-(diphenylmethyl)-1,3,4-oxadiazole-2(3<italic>H</italic>)-thione <bold>3</bold> was synthesized by adopting the method described in our earlier work [<xref ref-type="bibr" rid="B19-molbank-2013-M800">19</xref>]. </p>
      <p>To a solution of 5-(diphenylmethyl)-1,3,4-oxadiazole-2(3<italic>H</italic>)-thione <bold>3</bold> (0.44 g, 1.65 mmol) in dry acetone (25 mL), anhydrous potassium carbonate (0.27 g, 1.98 mmol) and 2-chloro-<italic>N</italic>-(pyrazin-2-yl)acetamide <bold>2</bold> (0.34 g, 1.98 mmol) were added and the resulting solution was heated to reflux for 4 hours. After the completion of reaction as indicated by TLC, the reaction mixture was cooled to room temperature and quenched into ice cold water. The resulting precipitate was filtered and recrystallized from ethanol. The yield was 0.73 g, 71%.</p>
      <p>Melting point: 210&#x2013;212 &#xB0;C. </p>
      <p>LCMS: <italic>m/z</italic> = 404.5 (M<sup>+</sup>+1).</p>
      <p>IR (KBr): &#x3BD;<sub>max</sub> (cm<sup>&#x2212;1</sup>), 3201 (N-H), 3041 (Ar-H), 1699 (alkyl-CO-NH) , 1555 (C=N, Ar C=C).</p>
      <p><sup>1</sup>H-NMR (400 MHz, DMSO-<italic>d</italic><sub>6</sub>): &#x3B4; ppm, 4.53 (s, 2H, S-CH<sub>2</sub>), 5.93 (s, 1H, Ph<sub>2</sub>-CH), 7.22&#x2013;7.36 (m, 11H, Ar-H), 8.38&#x2013;8.41 (m, 2H, Ar-H), 11.15 (s, 1H, NH).</p>
      <p><sup>13</sup>C-NMR (100 MHz, DMSO-<italic>d</italic><sub>6,</sub>): &#x3B4; ppm, 168.52 (C=O), 166.41, 163.89 (oxadiazole C&#x2019;s), 148.75, 143.11, 140.54, 139.07, 136.55, 129.14, 128.75, 127.82 (aromatic C&#x2019;s), 47.61(S-CH<sub>2</sub>), 36.78 (Ph<sub>2</sub>-CH).</p>
      <p>Elemental analysis: Calculated for C<sub>21</sub>H<sub>17</sub>N<sub>5</sub>O<sub>2</sub>S, C, 62.52%; H, 4.25%; N, 17.36%; Found: C, 62.49%; H, 4.28%; N, 17.32%.</p>
    </sec>
  </body>
  <back>
    <app-group>
    <app id="app1-molbank-2013-M800">
      <title>Supplementary materials</title>
    <supplementary-material id="molbank-2013-M800-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2013-M800-s001-mod.mol">
	<label>Supplementary File 1</label>
	</supplementary-material>
	<supplementary-material id="molbank-2013-M800-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2013-M800-s001.mol">
	<label>Supplementary File 2</label>
	</supplementary-material>
	<supplementary-material id="molbank-2013-M800-s003" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2013-M800-s002.pdf">
	<label>Supplementary File 3</label>
	</supplementary-material>
   </app>
    </app-group>
	<ack>
      <title>Acknowledgments</title>
      <p>The authors are thankful to IISc, Bangalore for NMR data. BN thanks the UGC for financial assistance through BSR one time grant for the purchase of chemicals. PSN thanks Mangalore University for research facilities and DST-PURSE for financial assistance. </p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2013-M800">
        <label>1.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Cremlyn</surname>
              <given-names>R.J.W.</given-names>
            </name>
          </person-group>
          <source>An Introduction to Organosulfur Chemistry</source>
          <publisher-name>Wiley</publisher-name>
          <publisher-loc>New York, NY, USA</publisher-loc>
          <year>1996</year>
        </citation>
      </ref>
      <ref id="B2-molbank-2013-M800">
        <label>2.</label>
        <citation citation-type="book">
          <person-group person-group-type="editor">
            <name>
              <surname>Oae</surname>
              <given-names>S.</given-names>
            </name>
			<name>
              <surname>Okuyama</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <source>Organic Sulfur Chemistry: Biochemical Aspects</source>
          <publisher-name>CRC</publisher-name>
          <publisher-loc>Boca Raton, FL, USA</publisher-loc>
          <year>1992</year>
        </citation>
      </ref>
      <ref id="B3-molbank-2013-M800">
        <label>3.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Weinshilboum</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Thiol S-methyltransferases, II: Pharmacogenetics</article-title>
          <source>Sulfur-Containing Drugs and Related Compounds Chemistry, Biochemistry and Toxicology</source>
          <person-group person-group-type="editor">
            <name>
              <surname>Damani</surname>
              <given-names>L.A.</given-names>
            </name>
          </person-group>
          <publisher-name>Ellis Horwood</publisher-name>
          <publisher-loc>Chichester, UK</publisher-loc>
          <year>1989</year>
          <volume>Volume 1</volume>
		  <comment>Part A, Chapter 1</comment>
        </citation>
      </ref>
      <ref id="B4-molbank-2013-M800">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McReynolds</surname>
              <given-names>M.D.</given-names>
            </name>
            <name>
              <surname>Doughtery</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Hanson</surname>
              <given-names>P.R.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of phosphorous and sulfur heterocycles <italic>via</italic> ring-closing metathesis</article-title>
          <source>Chem. Rev.</source>
          <year>2004</year>
          <volume>104</volume>
          <fpage>2239</fpage>
          <lpage>2258</lpage>
          <pub-id pub-id-type="doi">10.1021/cr020109k</pub-id>
          <pub-id pub-id-type="pmid">15137790</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2013-M800">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Macaev</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Rusu</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Pogrebnoi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Gudima</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Stingaci</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Vlad</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Shvets</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Kandemirli</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Dimoglo</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Reynolds</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of novel 5-aryl-2-thio-1,3,4-oxadiazoles and the study of their structure&#x2013;anti-mycobacterial activities</article-title>
          <source>Bioorg. Med. Chem.</source>
          <year>2005</year>
          <volume>13</volume>
          <fpage>4842</fpage>
          <lpage>4850</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmc.2005.05.011</pub-id>
          <pub-id pub-id-type="pmid">15993090</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2013-M800">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and fungicidal activity against rhizoctonia solani of 2-alkyl (alkylthio)-5-pyrazolyl-1,3,4-oxadiazoles (thiadiazoles)</article-title>
          <source>J. Agric. Food Chem.</source>
          <year>2000</year>
          <volume>48</volume>
          <fpage>5312</fpage>
          <lpage>5315</lpage>
          <pub-id pub-id-type="doi">10.1021/jf991065s</pub-id>
          <pub-id pub-id-type="pmid">11087478</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2013-M800">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Camper</surname>
              <given-names>N.D.</given-names>
            </name>
            <name>
              <surname>McDonald</surname>
              <given-names>S.K.</given-names>
            </name>
          </person-group>
          <article-title>Tissue and cell cultures as model system in herbicide research</article-title>
          <source>Rev. Weed Sci.</source>
          <year>1989</year>
          <volume>4</volume>
          <fpage>169</fpage>
          <lpage>190</lpage>
        </citation>
      </ref>
      <ref id="B8-molbank-2013-M800">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dolezal</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cmedlova</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Palek</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Vinsova</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kunes</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Buchta</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Jampilek</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kralova</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and antimycobacterial evaluation of substituted pyrazinecarboxamides</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2008</year>
          <volume>43</volume>
          <fpage>1105</fpage>
          <lpage>1113</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2007.07.013</pub-id>
          <pub-id pub-id-type="pmid">17870211</pub-id>
        </citation>
      </ref>
      <ref id="B9-molbank-2013-M800">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carta</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sanna</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Gherardini</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Usai</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Zanetti</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Novel functionalized pyrido[2,3-<italic>g</italic>]quinoxalinones as antibacterial, antifungal and anticancer agents</article-title>
          <source>II Farmaco</source>
          <year>2001</year>
          <volume>56</volume>
          <fpage>933</fpage>
          <lpage>938</lpage>
          <pub-id pub-id-type="doi">10.1016/S0014-827X(01)01161-2</pub-id>
        </citation>
      </ref>
      <ref id="B10-molbank-2013-M800">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Narayana</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Ashalatha</surname>
              <given-names>B.V.</given-names>
            </name>
            <name>
              <surname>Vijaya Raj</surname>
              <given-names>K.K.</given-names>
            </name>
            <name>
              <surname>Fernandes</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sarojini</surname>
              <given-names>B.K.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of some new biologically active 1,3,4-oxadiazolyl nitroindoles and a modified Fischer indole synthesis of ethyl nitro indole-2-carboxylates</article-title>
          <source>Bioorg. Med. Chem.</source>
          <year>2005</year>
          <volume>13</volume>
          <fpage>4638</fpage>
          <lpage>4644</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmc.2005.04.068</pub-id>
          <pub-id pub-id-type="pmid">15927475</pub-id>
        </citation>
      </ref>
      <ref id="B11-molbank-2013-M800">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Narayana</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Vijaya Raj</surname>
              <given-names>K.K.</given-names>
            </name>
            <name>
              <surname>Ashalatha</surname>
              <given-names>B.V.</given-names>
            </name>
            <name>
              <surname>Kumari</surname>
              <given-names>N.S.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of some new 2-(6 methoxy-2-naphthyl)- 5-aryl-1,3,4-oxadiazoles as possible non-steroidal anti-inflammatory and analgesic agents</article-title>
          <source>Arch. Pharm. (Weinheim)</source>
          <year>2005</year>
          <volume>338</volume>
          <fpage>373</fpage>
          <lpage>377</lpage>
          <pub-id pub-id-type="doi">10.1002/ardp.200500974</pub-id>
          <pub-id pub-id-type="pmid">16041838</pub-id>
        </citation>
      </ref>
      <ref id="B12-molbank-2013-M800">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mayekar</surname>
              <given-names>A.N.</given-names>
            </name>
            <name>
              <surname>Yathirajan</surname>
              <given-names>H.S.</given-names>
            </name>
            <name>
              <surname>Narayana</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Sarojini</surname>
              <given-names>B.K.</given-names>
            </name>
            <name>
              <surname>Kumari</surname>
              <given-names>N.S.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and antimicrobial studies on new substituted 1,3,4-oxadiazole derivatives bearing 6-bromo naphthalene moiety</article-title>
          <source>Int. J. Chem.</source>
          <year>2010</year>
          <volume>2</volume>
          <fpage>38</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="doi">10.5539/ijc.v2n1p38</pub-id>
        </citation>
      </ref>
      <ref id="B13-molbank-2013-M800">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bharadwaj</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Sara</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis, evaluation and characterization of some 1,3,4-oxadiazoles as antimicrobial agents</article-title>
          <source>Eur. J. Chem.</source>
          <year>2009</year>
          <volume>6</volume>
          <fpage>1133</fpage>
          <lpage>1138</lpage>
        </citation>
      </ref>
      <ref id="B14-molbank-2013-M800">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hall</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Chowdhury</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Giblin</surname>
              <given-names>G.M.P.</given-names>
            </name>
            <name>
              <surname>Gibson</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Healy</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Livermore</surname>
              <given-names>D.G.</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>R.J.M.</given-names>
            </name>
            <name>
              <surname>Naylor</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Rawlings</surname>
              <given-names>D.A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification and optimization of novel 1,3,4-oxadiazole EP1 receptor antagonists</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2007</year>
          <volume>17</volume>
          <fpage>4450</fpage>
          <lpage>4455</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2007.06.014</pub-id>
          <pub-id pub-id-type="pmid">17574410</pub-id>
        </citation>
      </ref>
      <ref id="B15-molbank-2013-M800">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abdel-Hamid</surname>
              <given-names>M.K.</given-names>
            </name>
            <name>
              <surname>Abdel-Hafez</surname>
              <given-names>A.A.</given-names>
            </name>
            <name>
              <surname>El-Koussi</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Mahfouz</surname>
              <given-names>N.M.</given-names>
            </name>
            <name>
              <surname>Innocenti</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Supuran</surname>
              <given-names>C.T.</given-names>
            </name>
          </person-group>
          <article-title>Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity</article-title>
          <source>Bioorg. Med. Chem.</source>
          <year>2007</year>
          <volume>15</volume>
          <fpage>6975</fpage>
          <lpage>6984</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmc.2007.07.044</pub-id>
          <pub-id pub-id-type="pmid">17822907</pub-id>
        </citation>
      </ref>
      <ref id="B16-molbank-2013-M800">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amir</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Javed</surname>
              <given-names>S.A.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and pharmacological evaluation of condensed heterocyclic 6-substituted-1,2,4-triazolo[3,4-<italic>b</italic>]-1,3,4-thiadiazole derivatives of naproxen</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2007</year>
          <volume>17</volume>
          <fpage>4504</fpage>
          <lpage>4508</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2007.06.003</pub-id>
          <pub-id pub-id-type="pmid">17576062</pub-id>
        </citation>
      </ref>
      <ref id="B17-molbank-2013-M800">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pastorin</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>da Ros</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Bolcato</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Montopoli</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Moro</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cacciari</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Baraldi</surname>
              <given-names>P.G.</given-names>
            </name>
            <name>
              <surname>Varani</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Borea</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Spalluto</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and biological studies of a new series of 5-heteroaryl carbamoylaminopyrazolo[4,3-<italic>e</italic>]1,2,4-triazolo[1,5-<italic>c</italic>]pyrimidines as human A3 adenosine receptor antagonists. Influence of the heteroaryl substituent on binding affinity and molecular modeling investigations</article-title>
          <source>J. Med. Chem.</source>
          <year>2006</year>
          <volume>49</volume>
          <fpage>1720</fpage>
          <lpage>1729</lpage>
          <pub-id pub-id-type="pmid">16509587</pub-id>
        </citation>
      </ref>
      <ref id="B18-molbank-2013-M800">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hassan</surname>
              <given-names>G.S.</given-names>
            </name>
            <name>
              <surname>El-Messery</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Al-Omary</surname>
              <given-names>F.A.M.</given-names>
            </name>
            <name>
              <surname>El-Subbagh</surname>
              <given-names>H.I.</given-names>
            </name>
          </person-group>
          <article-title>Substituted thiazoles VII. Synthesis and antitumor activity of certain 2-(substituted amino)-4-phenyl-1,3-thiazole analogs</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2012</year>
          <volume>22</volume>
          <fpage>6318</fpage>
          <lpage>6323</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2012.08.095</pub-id>
          <pub-id pub-id-type="pmid">22995621</pub-id>
        </citation>
      </ref>
      <ref id="B19-molbank-2013-M800">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Samshuddin</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Narayana</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Sarojini</surname>
              <given-names>B.K.</given-names>
            </name>
            <name>
              <surname>Shetty</surname>
              <given-names>D.N.</given-names>
            </name>
			<name>
              <surname>Kumari</surname>
              <given-names>N.S.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis, characterization, and biological evaluation of some new functionalized terphenyl derivatives</article-title>
          <source>Int. J. Med. Chem.</source>
          <year>2012</year>
          <volume>2012</volume>
          <pub-id pub-id-type="doi">10.1155/2012/530392</pub-id>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Scheme</title>
      <fig id="molbank-2013-M800-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2013-M800-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>Synthesis of 2-{[5-(diphenylmethyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-<italic>N</italic>-(pyrazin-2-yl) acetamide, <bold>4</bold>.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2013-M800-sch001.tif"/>
      </fig>
    </sec>
  </back>
</article>
